PCR reagent for detecting tumor medicine targets, and application of PCR reagent
A tumor drug, target technology, applied in the field of molecular biology, can solve the problem of liver cancer insensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0294] The present invention is illustrated by Sorafenib-treated human liver cancer Huh7 and liver cancer cell Huh7, but the present invention is not limited to these two types of cells, and the detection reagent of the present invention can be applied to liver cancer cell lines including SMMC7721, HCCLM3, etc., while It can also detect drug targets in clinical liver cancer tissues and paracancerous tissues of lung cancer, kidney cancer, gastric cancer, pancreatic cancer, ovarian cancer, glioma and other tumors.
[0295] The present invention cultures the human liver cancer cell line Huh7, then treats it with sorafenib (10uM) for 24 hours, and uses tumor drug target screening PCR reagents to detect the change of the core drug target molecule in the treated cell line.
[0296] The human liver cancer Huh7 used in the present invention was purchased from ATCC Company of the United States, the Shanghai Cell Bank, DMEM medium, and fetal bovine serum were purchased from Gibco Company...
PUM
Property | Measurement | Unit |
---|---|---|
emission peak | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com